The Schistosoma bovis Sb14-3-3ζ recombinant protein cross-protects against Schistosoma mansoni in BALB/c mice

Vaccine

Volumn 25, Issue 41, 2007, Pages 7217-7223

  Siles Lucas, M ^a   Uribe, N ^a,b   Lopez Aban J ^a   Vicente, B ^a   Orfao, A ^a   Nogal Ruiz, J J ^c   Feliciano, A San ^a   Muro, A ^a  

^a UNIVERSITY OF SALAMANCA   (Spain)

^b UNIVERSIDAD DE PAMPLONA   (Colombia)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

14 3 3 vaccination; Immunomodulators; Schistosoma

Indexed keywords

AMINOALCOHOL; CPG OLIGODEOXYNUCLEOTIDE; CPG OLIGODEOXYNUCLEOTIDE 1826; GAMMA INTERFERON; IMMUNOLOGICAL ADJUVANT; IMMUNOMODULATING AGENT; INTERLEUKIN 4; POLYPODIUM LEUCOTOMOS EXTRACT; RECOMBINANT PROTEIN; SCHISTOSOME 14 3 3 ZETA PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CROSS REACTION; CYTOKINE PRODUCTION; FEMALE; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOMODULATION; INFECTION PREVENTION; INFECTION RATE; INTERFERON PRODUCTION; INTESTINE MUCOSA; LIVER; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SCHISTOSOMA BOVIS; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; WORM EGG;

ANIMALS; ANTIBODIES, HELMINTH; BLOOD; CROSS REACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HELMINTH PROTEINS; IMMUNOGLOBULIN G; IMMUNOLOGIC FACTORS; INTERFERON TYPE II; INTERLEUKIN-4; INTESTINES; LIVER; MICE; MICE, INBRED BALB C; PARASITE EGG COUNT; RECOMBINANT PROTEINS; SCHISTOSOMA; SCHISTOSOMIASIS MANSONI; SPLEEN;

EID: 34648843570     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.07.021     Document Type: Article

References (27)

1. Hewitson J.P., Hamblin P.A., and Mountford A.P. Immunity induced by the radiation-attenuated schistosome vaccine. Parasite Immunol 27 7-8 (2005) 271-280
2. Bergquist R., Al-Sherbiny M., Barakat R., and Olds R. Blueprint for schistosomiasis vaccine development. Acta Tropica 82 2 (2002) 183-192
3. Ganley-Leal L.M., Guarner J., Todd C.W., Da'Dara A.A., Freeman Jr. G.L., Boyer A.E., et al. Comparison of Schistosoma mansoni irradiated cercariae and Sm23 DNA vaccines. Parasite Immunol 27 9 (2005) 341-349
4. Aitken A. 14-3-3 proteins: a historic overview. Semin Cancer Biol 16 3 (2006) 162-172
5. Siles-Lucas M., and Gottstein B. The 14-3-3 protein: a key molecule in parasites as in other organisms. Trends Parasitol 19 12 (2003) 575-581
6. Zhang Y., Taylor M.G., Johansen M.V., and Bickle Q.D. Vaccination of mice with a cocktail DNA vaccine induces a Th1-type immune response and partial protection against Schistosoma japonicum infection. Vaccine 20 5-6 (2001) 724-730
7. Li D.F., Chen Y.S., Zu Y., and Shen J.L. Construction of a novel Schistosoma japonicum DNA vaccine pBK-Sj14-3-3 and studies on its immunoprotection in mice. Zhonghua Yu Fang Yi Xue Za Zhi 38 3 (2004) 193-195
8. Schechtman D., Tarrab-Hazdai R., and Arnon R. The 14-3-3 protein as a vaccine candidate against schistosomiasis. Parasite Immunol 23 4 (2001) 213-217
9. Uribe N, Muro A, Vieira C, Lopez-Aban J, del Olmo E, Suarez L, et al. Genetic and immunological characterization of the 14-3-3ζ protein from Schistosoma bovis. J Parasitol, in press.
10. Uribe N., Siles-Lucas M., Lopez-Aban J., Esteban A., Suarez L., Martinez-Fernandez A., et al. The Sb14-3-3ζ recombinant protein protects against Schistosoma bovis in BALB/c mice. Vaccine 25 23 (2007) 4533-4539
11. Pardo J., Carranza C., Turrientes M.C., Perez Arellano J.L., Lopez Velez R., Ramajo V., et al. Utility of Schistosoma bovis adult worm antigens for diagnosis of human schistosomiasis by enzyme-linked immunosorbent assay and electroimmunotransfer blot techniques. Clin Diagn Lab Immunol 11 6 (2004) 1165-1170
12. Siles-Lucas M., Felleisen R.S., Hemphill A., Wilson W., and Gottstein B. Stage-specific expression of the 14-3-3 gene in Echinococcus multilocularis. Mol Biochem Parasitol 91 2 (1998) 281-293
13. Siles-Lucas M., Nunes C.P., and Zaha A. Comparative analysis of the 14-3-3 gene and its expression in Echinococcus granulosus and Echinococcus multilocularis metacestodes. Parasitology 122 Pt 3 (2001) 281-287
14. Kumar S., Jones T.R., Oakley M.S., Zheng H., Kuppusamy S.P., Taye A., et al. CpG oligodeoxynucleotide and Montanide ISA 51 adjuvant combination enhanced the protective efficacy of a subunit malaria vaccine. Infect Immun 72 (2004) 949-957
15. Martinez-Fernandez A.R., Nogal-Ruiz J.J., Lopez-Aban J., Ramajo V., Oleaga A., Manga-Gonzalez Y., et al. Vaccination of mice and sheep with Fh12 FABP from Fasciola hepatica using the new adjuvant/immunomodulator system ADAD. Vet Parasitol 126 3 (2004) 287-298
16. Olmo E.D., Plaza A., Muro A., Martinez-Fernandez A.R., Nogal-Ruiz J.J., Lopez-Perez J.L., et al. Synthesis and evaluation of some lipidic aminoalcohols and diamines as immunomodulators. Bioorg Med Chem Lett 16 23 (2006) 6091-6095
17. Dea-Ayuela M., Rodero M., Rodriguez-Bueno R., Bolas-Fernandez F., and Martinez-Fernandez A.R. Modulation by Anapsos (Polypodium leucotomos extract) of the antibody responses against the nematode parasite Trichinella spiralis. Phytother Res 13 (1999) 566-570
18. Nogal-Ruiz J.J., Gomez-Barrio A., Escario J.A., and Martinez-Fernandez A.R. Effect of Anapsos in a murine model of experimental trichomoniasis. Parasite 10 (2003) 303-308
19. Abane J.L., Oleaga A., Ramajo V., Casanueva P., Arellano J.L., Hillyer G.V., et al. Vaccination of mice against Schistosoma bovis with a recombinant fatty acid binding protein from Fasciola hepatica. Vet Parasitol 91 1-2 (2000) 33-42
20. Bosze S., Caccamo N., Majer Z., Mezo G., Dieli F., and Hudecz F. In vitro T-cell immunogenicity of oligopeptides derived from the region 92-110 of the 16-kDa protein of Mycobacterium tuberculosis. Biopolymers 76 (2004) 467-476
21. Zhang Y., Taylor M.G., McCrossan M.V., and Bickle Q.D. Molecular cloning and characterization of a novel Schistosoma japonicum "irradiated vaccine-specific" antigen, Sj14-3-3. Mol Biochem Parasitol 103 1 (1999) 25-34
22. Siles-Lucas M., Merli M., Mackenstedt U., and Gottstein B. The Echinococcus multilocularis 14-3-3 protein protects mice against primary but not secondary alveolar echinococcosis. Vaccine 21 5-6 (2003) 431-439
23. Krieg A.M., Love-Homan L., Yi A.K., and Harty J.T. CpG DNA induces sustained IL-12 expression in vivo and resistance to Listeria monocytogenes challenge. J Immunol 161 5 (1998) 2428-2434
24. Da'Dara A.A., Skelly P.J., Walker C.M., and Harn D.A. A DNA-prime/protein-boost vaccination regimen enhances Th2 immune responses but not protection following Schistosoma mansoni infection. Parasite Immunol 25 8-9 (2003) 429-437
25. Fonseca C.T., Brito C.F., Alves J.B., and Oliveira S.C. IL-12 enhances protective immunity in mice engendered by immunization with recombinant 14 kDa Schistosoma mansoni fatty acid-binding protein through an IFN-gamma and TNF-alpha dependent pathway. Vaccine 22 3-4 (2004) 503-510
26. Siddiqui A.A., Pinkston J.R., Quinlin M.L., Kavikondala V., Rewers-Felkins K.A., Phillips T., et al. Characterization of protective immunity induced against Schistosoma mansoni via DNA priming with the large subunit of calpain (Sm-p80) in the presence of genetic adjuvants. Parasite 12 1 (2005) 3-8
27. Maizels R.M., and Yazdanbakhsh M. Immune regulation by helminth parasites: cellular and molecular mechanisms. Nat Rev Immunol 3 9 (2003) 733-744